These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9200010

  • 1. Attitudes and beliefs of family physicians and gynecologists in relation to the prevention and treatment of osteoporosis.
    Suarez-Almazor M, Homik JE, Messina D, Davis P.
    J Bone Miner Res; 1997 Jul; 12(7):1100-7. PubMed ID: 9200010
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH.
    J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
    [Abstract] [Full Text] [Related]

  • 5. Hormone replacement therapy: a survey of Ontario physicians' prescribing practices.
    Elinson L, Cohen MM, Elmslie T.
    CMAJ; 1999 Sep 21; 161(6):695-8. PubMed ID: 10513275
    [Abstract] [Full Text] [Related]

  • 6. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM, McCarthy EP, Davis RB, Phillips RS.
    J Womens Health (Larchmt); 2003 Jun 21; 12(5):495-504. PubMed ID: 12869297
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May 21; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 8. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C.
    Bone; 2004 Apr 21; 34(4):728-35. PubMed ID: 15050905
    [Abstract] [Full Text] [Related]

  • 9. Swedish gynecologists' and general practitioners' views on the climacteric period: knowledge, attitudes and management strategies.
    Andersson K, Pedersen AT, Mattsson LA, Milsom I.
    Acta Obstet Gynecol Scand; 1998 Oct 21; 77(9):909-16. PubMed ID: 9808379
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?
    Sirola J, Kröger H, Honkanen R, Sandini L, Tuppurainen M, Jurvelin JS, Saarikoski S.
    Osteoporos Int; 2003 Jan 21; 14(1):27-33. PubMed ID: 12577182
    [Abstract] [Full Text] [Related]

  • 14. A review of combination regimens for osteoporosis--prevention and treatment.
    Miller E, Kalin MF.
    Int J Fertil Womens Med; 2002 Jan 21; 47(5):198-204. PubMed ID: 12469706
    [Abstract] [Full Text] [Related]

  • 15. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ, Boulet MJ.
    Obstet Gynecol; 1997 Aug 21; 90(2):269-77. PubMed ID: 9241307
    [Abstract] [Full Text] [Related]

  • 16. Bone mineral density in relation to medical and lifestyle risk factors for osteoporosis in premenopausal, menopausal and postmenopausal women in general practice.
    McKnight A, Steele K, Mills K, Gilchrist C, Taggart H.
    Br J Gen Pract; 1995 Jun 21; 45(395):317-20. PubMed ID: 7619589
    [Abstract] [Full Text] [Related]

  • 17. Do clinicians prescribe HRT for hypertensive postmenopausal women?
    Lip G, Beevers M, Churchill D, Beevers DG.
    Br J Clin Pract; 1995 Jun 21; 49(2):61-4. PubMed ID: 7779644
    [Abstract] [Full Text] [Related]

  • 18. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
    Menopause; 2000 Jun 21; 7(2):76-86. PubMed ID: 10746889
    [Abstract] [Full Text] [Related]

  • 19. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M, Vacca F.
    Minerva Med; 2004 Dec 21; 95(6):507-20. PubMed ID: 15785435
    [Abstract] [Full Text] [Related]

  • 20. Use of hormone replacement therapy in Washington State: is prevention being put into practice?
    Saver BG, Taylor TR, Woods NF.
    J Fam Pract; 1999 May 21; 48(5):364-71. PubMed ID: 10334613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.